Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
-- | -- | -- | -- | -- |
|
AGL
Agilon Health, Inc.
|
$1.5B | -$0.27 | -4.03% | -6.74% | $0.97 |
|
AMS
American Shared Hospital Services
|
$8.8M | $0.02 | -3.19% | -100% | $4.50 |
|
CCEL
Cryo-Cell International, Inc.
|
$7.7M | -$0.09 | -4.04% | -60.92% | $8.50 |
|
INNV
InnovAge Holding Corp.
|
$228.3M | $0.04 | 9.24% | -100% | $5.00 |
|
SNDA
Sonida Senior Living, Inc.
|
-- | -- | -- | -- | $28.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
$130.93 | -- | $2B | 20.20x | $0.64 | 1.93% | 1.37x |
|
AGL
Agilon Health, Inc.
|
$0.69 | $0.97 | $287.1M | -- | $0.00 | 0% | 0.05x |
|
AMS
American Shared Hospital Services
|
$2.18 | $4.50 | $14.3M | 11.73x | $0.00 | 0% | 0.49x |
|
CCEL
Cryo-Cell International, Inc.
|
$3.57 | $8.50 | $28.8M | 498.00x | $0.15 | 18.21% | 0.91x |
|
INNV
InnovAge Holding Corp.
|
$5.48 | $5.00 | $743.5M | -- | $0.00 | 0% | 0.84x |
|
SNDA
Sonida Senior Living, Inc.
|
$31.96 | $28.00 | $602.9M | -- | $0.00 | 0% | 1.56x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
10.84% | 0.680 | 7.3% | 1.23x |
|
AGL
Agilon Health, Inc.
|
10.82% | -4.110 | 8.69% | 0.25x |
|
AMS
American Shared Hospital Services
|
50.05% | 0.193 | 110.57% | 1.02x |
|
CCEL
Cryo-Cell International, Inc.
|
-564.01% | 1.765 | 33.28% | 0.78x |
|
INNV
InnovAge Holding Corp.
|
28.59% | 2.208 | 13.42% | 0.96x |
|
SNDA
Sonida Senior Living, Inc.
|
89.42% | 0.268 | 118.09% | 0.35x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
$131.4M | -$87.2M | 8.6% | 10.22% | -22.9% | $56.5M |
|
AGL
Agilon Health, Inc.
|
-$75.1M | -$127.2M | -65.38% | -71.4% | -8.86% | -$34.7M |
|
AMS
American Shared Hospital Services
|
$1.6M | $48K | -6.67% | -12.09% | 0.67% | -$2M |
|
CCEL
Cryo-Cell International, Inc.
|
$5.8M | $1.9M | -20.01% | -- | 24.29% | $2.5M |
|
INNV
InnovAge Holding Corp.
|
$46.3M | $10.3M | -5.79% | -7.99% | 4.34% | -$153K |
|
SNDA
Sonida Senior Living, Inc.
|
$6M | -$10.9M | -6.31% | -41.74% | -11.17% | $3M |
Agilon Health, Inc. has a net margin of 10.77% compared to National HealthCare Corp.'s net margin of -7.68%. National HealthCare Corp.'s return on equity of 10.22% beat Agilon Health, Inc.'s return on equity of -71.4%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
34.5% | $2.51 | $1.2B |
|
AGL
Agilon Health, Inc.
|
-5.23% | -$0.27 | $343.2M |
National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Agilon Health, Inc. has an analysts' consensus of $0.97 which suggests that it could grow by 39.35%. Given that Agilon Health, Inc. has higher upside potential than National HealthCare Corp., analysts believe Agilon Health, Inc. is more attractive than National HealthCare Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
0 | 0 | 0 |
|
AGL
Agilon Health, Inc.
|
2 | 13 | 0 |
National HealthCare Corp. has a beta of 0.645, which suggesting that the stock is 35.519% less volatile than S&P 500. In comparison Agilon Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.93%. Agilon Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 37.04% of its earnings as a dividend. Agilon Health, Inc. pays out -- of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
National HealthCare Corp. quarterly revenues are $380.8M, which are smaller than Agilon Health, Inc. quarterly revenues of $1.4B. National HealthCare Corp.'s net income of $41M is higher than Agilon Health, Inc.'s net income of -$110.2M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 20.20x while Agilon Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.37x versus 0.05x for Agilon Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
1.37x | 20.20x | $380.8M | $41M |
|
AGL
Agilon Health, Inc.
|
0.05x | -- | $1.4B | -$110.2M |
American Shared Hospital Services has a net margin of 10.77% compared to National HealthCare Corp.'s net margin of -4.59%. National HealthCare Corp.'s return on equity of 10.22% beat American Shared Hospital Services's return on equity of -12.09%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
34.5% | $2.51 | $1.2B |
|
AMS
American Shared Hospital Services
|
21.94% | -$0.00 | $53.2M |
National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand American Shared Hospital Services has an analysts' consensus of $4.50 which suggests that it could grow by 106.42%. Given that American Shared Hospital Services has higher upside potential than National HealthCare Corp., analysts believe American Shared Hospital Services is more attractive than National HealthCare Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
0 | 0 | 0 |
|
AMS
American Shared Hospital Services
|
0 | 0 | 0 |
National HealthCare Corp. has a beta of 0.645, which suggesting that the stock is 35.519% less volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.120, suggesting its less volatile than the S&P 500 by 88.028%.
National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.93%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 37.04% of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
National HealthCare Corp. quarterly revenues are $380.8M, which are larger than American Shared Hospital Services quarterly revenues of $7.2M. National HealthCare Corp.'s net income of $41M is higher than American Shared Hospital Services's net income of -$329K. Notably, National HealthCare Corp.'s price-to-earnings ratio is 20.20x while American Shared Hospital Services's PE ratio is 11.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.37x versus 0.49x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
1.37x | 20.20x | $380.8M | $41M |
|
AMS
American Shared Hospital Services
|
0.49x | 11.73x | $7.2M | -$329K |
Cryo-Cell International, Inc. has a net margin of 10.77% compared to National HealthCare Corp.'s net margin of 9.58%. National HealthCare Corp.'s return on equity of 10.22% beat Cryo-Cell International, Inc.'s return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
34.5% | $2.51 | $1.2B |
|
CCEL
Cryo-Cell International, Inc.
|
74.61% | $0.09 | -$2.2M |
National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Cryo-Cell International, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 138.1%. Given that Cryo-Cell International, Inc. has higher upside potential than National HealthCare Corp., analysts believe Cryo-Cell International, Inc. is more attractive than National HealthCare Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
0 | 0 | 0 |
|
CCEL
Cryo-Cell International, Inc.
|
0 | 1 | 0 |
National HealthCare Corp. has a beta of 0.645, which suggesting that the stock is 35.519% less volatile than S&P 500. In comparison Cryo-Cell International, Inc. has a beta of 0.689, suggesting its less volatile than the S&P 500 by 31.12%.
National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.93%. Cryo-Cell International, Inc. offers a yield of 18.21% to investors and pays a quarterly dividend of $0.15 per share. National HealthCare Corp. pays 37.04% of its earnings as a dividend. Cryo-Cell International, Inc. pays out 510.2% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Cryo-Cell International, Inc.'s is not.
National HealthCare Corp. quarterly revenues are $380.8M, which are larger than Cryo-Cell International, Inc. quarterly revenues of $7.8M. National HealthCare Corp.'s net income of $41M is higher than Cryo-Cell International, Inc.'s net income of $749.4K. Notably, National HealthCare Corp.'s price-to-earnings ratio is 20.20x while Cryo-Cell International, Inc.'s PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.37x versus 0.91x for Cryo-Cell International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
1.37x | 20.20x | $380.8M | $41M |
|
CCEL
Cryo-Cell International, Inc.
|
0.91x | 498.00x | $7.8M | $749.4K |
InnovAge Holding Corp. has a net margin of 10.77% compared to National HealthCare Corp.'s net margin of 3.25%. National HealthCare Corp.'s return on equity of 10.22% beat InnovAge Holding Corp.'s return on equity of -7.99%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
34.5% | $2.51 | $1.2B |
|
INNV
InnovAge Holding Corp.
|
19.6% | $0.06 | $373.8M |
National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand InnovAge Holding Corp. has an analysts' consensus of $5.00 which suggests that it could fall by -8.76%. Given that InnovAge Holding Corp. has higher upside potential than National HealthCare Corp., analysts believe InnovAge Holding Corp. is more attractive than National HealthCare Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
0 | 0 | 0 |
|
INNV
InnovAge Holding Corp.
|
0 | 2 | 0 |
National HealthCare Corp. has a beta of 0.645, which suggesting that the stock is 35.519% less volatile than S&P 500. In comparison InnovAge Holding Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.93%. InnovAge Holding Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 37.04% of its earnings as a dividend. InnovAge Holding Corp. pays out -- of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
National HealthCare Corp. quarterly revenues are $380.8M, which are larger than InnovAge Holding Corp. quarterly revenues of $236.1M. National HealthCare Corp.'s net income of $41M is higher than InnovAge Holding Corp.'s net income of $7.7M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 20.20x while InnovAge Holding Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.37x versus 0.84x for InnovAge Holding Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
1.37x | 20.20x | $380.8M | $41M |
|
INNV
InnovAge Holding Corp.
|
0.84x | -- | $236.1M | $7.7M |
Sonida Senior Living, Inc. has a net margin of 10.77% compared to National HealthCare Corp.'s net margin of -27.9%. National HealthCare Corp.'s return on equity of 10.22% beat Sonida Senior Living, Inc.'s return on equity of -41.74%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
34.5% | $2.51 | $1.2B |
|
SNDA
Sonida Senior Living, Inc.
|
6.09% | -$1.56 | $770.8M |
National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sonida Senior Living, Inc. has an analysts' consensus of $28.00 which suggests that it could fall by -12.39%. Given that Sonida Senior Living, Inc. has higher upside potential than National HealthCare Corp., analysts believe Sonida Senior Living, Inc. is more attractive than National HealthCare Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NHC
National HealthCare Corp.
|
0 | 0 | 0 |
|
SNDA
Sonida Senior Living, Inc.
|
0 | 1 | 0 |
National HealthCare Corp. has a beta of 0.645, which suggesting that the stock is 35.519% less volatile than S&P 500. In comparison Sonida Senior Living, Inc. has a beta of 0.620, suggesting its less volatile than the S&P 500 by 38.032%.
National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.93%. Sonida Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 37.04% of its earnings as a dividend. Sonida Senior Living, Inc. pays out 85.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
National HealthCare Corp. quarterly revenues are $380.8M, which are larger than Sonida Senior Living, Inc. quarterly revenues of $98M. National HealthCare Corp.'s net income of $41M is higher than Sonida Senior Living, Inc.'s net income of -$27.3M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 20.20x while Sonida Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.37x versus 1.56x for Sonida Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NHC
National HealthCare Corp.
|
1.37x | 20.20x | $380.8M | $41M |
|
SNDA
Sonida Senior Living, Inc.
|
1.56x | -- | $98M | -$27.3M |
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.